Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Multicompartmental Pharmacokinetics of Tenofovir 1% Gel Using the BAT 24 Regimen Versus Daily and Single Pericoital Dosing.

Schwartz JL, Weiner D, Kashuba A, Archer D, Brache V, Schreiber CA, Chen BA, Poindexter A, Thurman A, Lai JJ, Yang KH, Sykes C, Mauck C, Herold B, Dezzutti C, Doncel GF.

AIDS Res Hum Retroviruses. 2014 Oct;30 Suppl 1:A37. doi: 10.1089/aid.2014.5060.abstract. No abstract available.

PMID:
25357839
[PubMed - in process]
2.

Short-term aerobic exercise and vascular function in CKD stage 3: a randomized controlled trial.

Headley S, Germain M, Wood R, Joubert J, Milch C, Evans E, Poindexter A, Cornelius A, Brewer B, Pescatello LS, Parker B.

Am J Kidney Dis. 2014 Aug;64(2):222-9. doi: 10.1053/j.ajkd.2014.02.022. Epub 2014 Apr 26.

PMID:
24776325
[PubMed - indexed for MEDLINE]
3.

Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.

Archer DF, Pinkerton JV, Guico-Pabia CJ, Hwang E, Cheng RF; Study 3353 Investigators.

Menopause. 2013 Jan;20(1):47-56. doi: 10.1097/gme.0b013e3182775fe9.

PMID:
23266840
[PubMed - indexed for MEDLINE]
4.

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.

Pinkerton JV, Constantine G, Hwang E, Cheng RF; Study 3353 Investigators.

Menopause. 2013 Jan;20(1):28-37. doi: 10.1097/gme.0b013e31826421a8.

PMID:
23010882
[PubMed - indexed for MEDLINE]
5.

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years.

Einstein MH, Baron M, Levin MJ, Chatterjee A, Fox B, Scholar S, Rosen J, Chakhtoura N, Meric D, Dessy FJ, Datta SK, Descamps D, Dubin G; HPV-010 Study Group.

Hum Vaccin. 2011 Dec;7(12):1343-58. doi: 10.4161/hv.7.12.18281. Epub 2011 Dec 1.

PMID:
22048173
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years.

Einstein MH, Baron M, Levin MJ, Chatterjee A, Fox B, Scholar S, Rosen J, Chakhtoura N, Lebacq M, van der Most R, Moris P, Giannini SL, Schuind A, Datta SK, Descamps D; HPV-010 Study Group.

Hum Vaccin. 2011 Dec;7(12):1359-73. doi: 10.4161/hv.7.12.18282. Epub 2011 Dec 1.

PMID:
22048172
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel.

Schwartz JL, Rountree W, Kashuba AD, Brache V, Creinin MD, Poindexter A, Kearney BP.

PLoS One. 2011;6(10):e25974. doi: 10.1371/journal.pone.0025974. Epub 2011 Oct 19.

PMID:
22039430
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.

Silverman SL, Chines AA, Kendler DL, Kung AW, Teglbjærg CS, Felsenberg D, Mairon N, Constantine GD, Adachi JD; Bazedoxifene Study Group.

Osteoporos Int. 2012 Jan;23(1):351-63. doi: 10.1007/s00198-011-1691-1. Epub 2011 Jul 21.

PMID:
21779819
[PubMed - indexed for MEDLINE]
9.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators.

Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.

PMID:
21663949
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years.

Einstein MH, Baron M, Levin MJ, Chatterjee A, Edwards RP, Zepp F, Carletti I, Dessy FJ, Trofa AF, Schuind A, Dubin G; HPV-010 Study Group.

Hum Vaccin. 2009 Oct;5(10):705-19. Epub 2009 Oct 14.

PMID:
19684472
[PubMed - indexed for MEDLINE]
Free Article
11.

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial.

Jadzinsky M, Pfützner A, Paz-Pacheco E, Xu Z, Allen E, Chen R; CV181-039 Investigators.

Diabetes Obes Metab. 2009 Jun;11(6):611-22. doi: 10.1111/j.1463-1326.2009.01056.x.

PMID:
19515181
[PubMed - indexed for MEDLINE]
12.

Safety evaluation of 1% tenofovir gel in healthy men.

Schwartz JL, Poindexter A, Wheeless A, Mauck CK, Callahan MM.

Int J STD AIDS. 2009 Jun;20(6):384-6. doi: 10.1258/ijsa.2008.008309.

PMID:
19451321
[PubMed - indexed for MEDLINE]
13.

Comparative crossover study of the PATH Woman's Condom and the FC Female Condom.

Schwartz JL, Barnhart K, Creinin MD, Poindexter A, Wheeless A, Kilbourne-Brook M, Mauck CK, Weiner DH, Callahan MM.

Contraception. 2008 Dec;78(6):465-73. doi: 10.1016/j.contraception.2008.07.020. Epub 2008 Sep 18.

PMID:
19014792
[PubMed - indexed for MEDLINE]
14.

Assessment of Implanon insertion and removal.

Levine JP, Sinofsky FE, Christ MF; Implanon US Study Group.

Contraception. 2008 Nov;78(5):409-17. doi: 10.1016/j.contraception.2008.06.016. Epub 2008 Sep 18.

PMID:
18929739
[PubMed - indexed for MEDLINE]
15.

Efficacy and safety of a 28-day oral contraceptive with 7 days of low-dose estrogen in place of placebo.

Poindexter A, Reape KZ, Hait H.

Contraception. 2008 Aug;78(2):113-9. doi: 10.1016/j.contraception.2008.04.001. Epub 2008 Jun 2.

PMID:
18672111
[PubMed - indexed for MEDLINE]
16.

Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.

Rovner ES, Rackley R, Nitti VW, Wang JT, Guan Z; 037 Study Group.

Urology. 2008 Sep;72(3):488-93. doi: 10.1016/j.urology.2008.05.019. Epub 2008 Jul 17.

PMID:
18639327
[PubMed - indexed for MEDLINE]
17.

Disparities in contraceptive knowledge, attitude and use between Hispanic and non-Hispanic whites.

Sangi-Haghpeykar H, Ali N, Posner S, Poindexter AN.

Contraception. 2006 Aug;74(2):125-32. Epub 2006 Apr 27.

PMID:
16860050
[PubMed - indexed for MEDLINE]
18.

Physicians' views and practices concerning menopausal hormone therapy.

Sangi-Haghpeykar H, Poindexter AN 3rd.

Maturitas. 2007 Jan 20;56(1):30-7. Epub 2006 Jun 21.

PMID:
16797148
[PubMed - indexed for MEDLINE]
19.

Consistency of condom use among low-income hormonal contraceptive users.

Sangi-Haghpeykar H, Posner SF, Poindexter AN 3rd.

Perspect Sex Reprod Health. 2005 Dec;37(4):184-91.

PMID:
16380364
[PubMed - indexed for MEDLINE]
20.

Differential mRNA processing in hematopoietic stem cells.

Bowman TV, McCooey AJ, Merchant AA, Ramos CA, Fonseca P, Poindexter A, Bradfute SB, Oliveira DM, Green R, Zheng Y, Jackson KA, Chambers SM, McKinney-Freeman SL, Norwood KG, Darlington G, Gunaratne PH, Steffen D, Goodell MA.

Stem Cells. 2006 Mar;24(3):662-70. Epub 2005 Dec 22.

PMID:
16373690
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk